Ablative Solutions tapped 30-year industry veteran Kate Rumrill, the former chief executive at NeoSync, to be its new president & CEO.
Rumrill, whose resume includes stints at Covidien, Aspect Medical Systems and Eli Lilly, is slated to keep her seat on NeoSync’s board, San Jose, Calif.-based Ablative Solutions said. The company makes the Peregine renal denervation device for reducing blood pressure in patients with uncontrolled hypertension.
“We’re enthusiastic to have someone with Kate’s unique background stepping into the leadership role at Ablative Solutions during this important time in the company’s clinical development. Her combined pharmaceutical and device experience will be extremely valuable as the company evaluates the drug/device combination Peregrine system kit in the Target BP clinical trial program,” chairman Dr. Michael Fulton, senior managing director at BioStar Capital, said in prepared remarks.
“I couldn’t be more thrilled to join Ablative Solutions at this very exciting time in the company’s growth. Our novel technology and talented team have the potential to create real value for our customers and shareholders alike,” Rumrill added. “With our promising early clinical data, I am excited to work with the team and our scientific advisors and physician partners to execute the new trials and deliver the clinical evidence required to make this therapy available for the large population suffering from uncontrolled hypertension. It is an honor to have the opportunity to work with such a dedicated and innovative group of entrepreneurs and scientists.”
ICU Medical CFO Lamb to retire
ICU Medical (NSDQ:ICUI) last week said that treasurer & CEO Scott Lamb is slated to retire early next year, to be replaced by finance VP Brian Bonnell after the company files its 2019 annual report with the U.S. Securities & Exchange Commission.
“Scott has been an integral part of ICU’s leadership team for many years,” CEO Vivek Jain said in prepared remarks. “On behalf of the board and our entire company, I would like to thank Scott for his dedication and many significant contributions. Scott joined the company when it was approximately $100 million in revenues and was a key contributor during our changes over the last five years.”
ICU Medical put up sales of $1.40 billion last year.
Glooko taps software industry exec Lien for CFO
Glooko said today that it named Stephen Lien as its new finance chief.
“We’re very excited to have a seasoned finance and operations executive of Steve’s caliber joining the Glooko team, especially at this stage in our company’s development,” CEO Russ Johannesson said. “Steve is a leader with a strong track record for not only accelerating revenue and maximizing returns but also for scaling global businesses and taking them to the next level, and most recently, that has been with organizations focused on SaaS solutions in the healthcare space.”
Titan Medical lures Zaring from Medtronic for new CCO role
Titan Medical (TSX:TMD;OTC:TITFX) said it named Chad Zaring to fill the newly created role of chief commercial officer.
Zaring, who was robotics, imaging & navigation VP at Medtronic, joined that company when it acquired Mazor Robotics, where he was vice president of national accounts and later VP of U.S. sales. Zaring got his start in robot-assisted surgery with industry pioneer Intuitive Surgical.
“Chad is the ideal professional to lead the commercialization of our single-port robotic surgical system, and we are thrilled he has chosen to join Titan Medical,” CEO David McNally said. “The timing couldn’t be better. We are at an inflection point in our company’s development as we prepare for successful execution of preclinical and clinical studies that will permit us to file for regulatory clearances both in the U.S. and the EU by the end of the year. We look forward to having such a talented and broadly experienced individual as Chad execute our sales strategy and further strengthen our in-house robotic commercial launch expertise.”
Longtime Intuitive Surgical COO Brogna to retire
Intuitive Surgical (NSDQ:ISRG) last week revealed the impending departure of longtime COO Sal Brogna, who’s slated to depart at the end of the year following a two-decade career with Intuitive.
Brogna, who’s due to become a consultant and advisor to the company starting in 2020, started at the robot-assisted surgery pioneer in October 1999.
“Over the past several years, we have formed a strong product operations leadership team,” Brogna said. “[T]hey are ready to carry operations at Intuitive forward.”
“I am thankful for the opportunity Intuitive has afforded me to work with outstanding people inside and outside the organization and proud of the progress we’ve made together in the past two decades,” he added. “At this point in my career, I look forward to stepping back from day-to-day operations and contributing to the solution of some of healthcare’s challenges from a broader vantage point.”
“Sal’s contributions to Intuitive have been invaluable,” president & CEO Gary Guthart said. “During his long tenure with the company, he has played key roles in developing and supplying our portfolio of surgical systems, and in developing the next generation of company leadership. I extend my personal thanks and the thanks of the company for his many contributions, and look forward to continuing our work together in an advisory capacity.”
- Stimwave Technologies signs football great Joe Montana as spokesman
- Cardinal Health promotes Mason to succeed Giacomin as medical segment CEO
- Orthofix global spine prez Niemann heads for the door
- Ocular Therapeutix appoints ex-Silver Creek COO White as biz dev SVP
- Mann to succeed Nodiff as Cantel Medical GC after 32 years